Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
People with hemophilia A using emicizumab in Brazil
RBR-57rnpzRecruiting
- Sponsor
- Universidade Federal de Minas Gerais
- Start
- Jan 2020
- Modality
- Bispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of emicizumab in hemophilia A, sponsored by Universidade Federal de Minas Gerais. Started Jan 2020; status: recruiting.
02
Drugs
emicizumab
03
Conditions
hemophilia A
Beyond the preview
Go deeper on RBR-57rnpz.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-57rnpz.